ASO Visual Abstract: A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma Raghav TripathiKaren LarsonWesley Y. Yu ASO Visual Abstract 15 April 2023 Pages: 4331 - 4332
The Use of Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye in Sentinel Lymph Node Biopsy in Cutaneous Melanoma: A Retrospective, Cohort Study Michael G. FadelSidra RaufMyles J. Smith Melanoma 16 April 2023 Pages: 4333 - 4340
ASO Author Reflections: Comparison of Indocyanine Green with Blue Dye in Sentinel Lymph Node Biopsy for Cutaneous Melanoma Michael G. FadelMyles J. Smith ASO Author Reflections Open access 04 April 2023 Pages: 4341 - 4342
ASO Visual Abstract: The Use of Indocyanine Green and Near-Infrared Fluorescence Imaging Versus Blue Dye in Sentinel Lymph Node Biopsy in Cutaneous Melanoma: A Retrospective, Cohort Study Michael G. FadelSidra RaufMyles J. Smith ASO Visual Abstract 21 April 2023 Pages: 4343 - 4344
Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma Kevin L. MaCimarron E. SharonJohn T. Miura Melanoma 27 April 2023 Pages: 4345 - 4355
ASO Author Reflections: Radiation or Completion Dissection for the Lymph Node Basin in Micrometastatic Merkel Cell Carcinoma: A National Cohort Kevin L. MaGiorgos C. KarakousisJohn T. Miura ASO Author Reflections 28 April 2023 Pages: 4356 - 4356
ASO Visual Abstract: Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma Kevin L. MaCimarron E. SharonJohn T. Miura ASO Visual Abstract 29 April 2023 Pages: 4357 - 4358
Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma John F. ThompsonJohn HyngstromMark B. Faries Melanoma 06 May 2023 Pages: 4359 - 4360
Regarding: "Predicting Regional Lymph Node Recurrence in the Modern Age of Tumor-Positive Sentinel Node Melanoma," by Faries, Mark et al. Richard EssnerJennifer Keller Melanoma 12 May 2023 Pages: 4361 - 4362
Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving versus Non-Minority-Serving Hospitals Henrique A. LimaLaura AlaimoTimothy M. Pawlik Pancreatic Tumors 17 February 2023 Pages: 4363 - 4372
ASO Author Reflections: Disparities in NCCN Guideline-Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving Versus Non-minority-Serving Hospitals Henrique A. LimaZorays MoazzamTimothy M. Pawlik ASO Author Reflections 18 February 2023 Pages: 4373 - 4374
ASO Visual Abstract: Disparities in NCCN Guideline Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals Henrique A. LimaLaura AlaimoTimothy M. Pawlik ASO Visual Abstract 22 March 2023 Pages: 4375 - 4376
Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter? Gilbert Z. MurimwaJohn D. KaralisPatricio M. Polanco Pancreatic Tumors 25 March 2023 Pages: 4377 - 4387
ASO Author Reflections: Expanding Guideline Concordant Care: The Time for a National Accreditation Program for Pancreatic Cancer is Now Gilbert Z. MurimwaJennie MeierPatricio M. Polanco ASO Author Reflections 21 March 2023 Pages: 4388 - 4389
ASO Visual Abstract: Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer: Do They Matter? Gilbert Z. MurimwaJohn D. KaralisPatricio M. Polanco ASO Visual Abstract 13 April 2023 Pages: 4390 - 4391
Propensity Score Matching Analysis of the Safety of Completion Total Pancreatectomy for Remnant Pancreatic Tumors Versus that of Initial Total Pancreatectomy for Primary Pancreatic Tumors Eisho KanemitsuToshihiko MasuiEtsuro Hatano Pancreatic Tumors 18 March 2023 Pages: 4392 - 4406
ASO Author Reflections: Evaluating the Safety of Completion Total Pancreatectomy Compared with Initial Total Pancreatectomy Eisho KanemitsuToshihiko MasuiEtsuro Hatano ASO Author Reflections 18 March 2023 Pages: 4407 - 4408
ASO Visual Abstract: Propensity Score-Matching Analysis of the Safety of Completion Total Pancreatectomy for Remnant Pancreatic Tumors Versus that of Initial Total Pancreatectomy for Primary Pancreatic Tumors Eisho KanemitsuToshihiko MasuiEtsuro Hatano ASO Visual Abstract 24 April 2023 Pages: 4409 - 4410
Two-Stage Class Ia Celiac Axis Resection with Superior Mesenteric Vein Reconstruction Jonathan GarnierAnaïs PalenOlivier Turrini Pancreatic Tumors 17 March 2023 Pages: 4411 - 4412
ASO Author Reflections: How to Tackle the Vascular Risk of Celiac Axis Resection for Pancreatic Cancer? Jonathan GarnierOlivier Turrini ASO Author Reflections 05 April 2023 Pages: 4413 - 4414
ASO Visual Abstract: Two-Stage Class Ia Celiac Axis Resection with Superior Mesenteric Vein Reconstruction Jonathan GarnierAnaïs PalenOlivier Turrini ASO Visual Abstract 04 April 2023 Pages: 4415 - 4416
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review Dilmurodjon EshmuminovBotirjon AminjonovKuno Lehmann Pancreatic Tumors Open access 05 April 2023 Pages: 4417 - 4428
ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal Dilmurodjon EshmuminovBotirjon AminjonovKuno Lehmann ASO Author Reflections Open access 19 April 2023 Pages: 4429 - 4430
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review Dilmurodjon EshmuminovBotirjon AminjonovKuno Lehmann ASO Visual Abstract 17 April 2023 Pages: 4431 - 4432
Feasibility and Safety of Laparoscopic D2 Gastrectomy in Combination with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Gastric Cancer at High Risk of Recurrence—The PIPAC-OPC4 Study Martin GraversenI. RouvelasM. B. Mortensen Peritoneal Surface Malignancy 03 March 2023 Pages: 4433 - 4441
ASO Visual Abstract: Feasibility and Safety of Laparoscopic D2 Gastrectomy in Combination with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Gastric Cancer at High Risk of Recurrence: The PIPAC-OPC4 Study M. GraversenI. RouvelasM. B. Mortensen ASO Visual Abstract 06 April 2023 Pages: 4442 - 4443
Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases Frédéric SchellAmaniel KefleyesusVahan Kepenekian Peritoneal Surface Malignancy 02 March 2023 Pages: 4444 - 4454
ASO Author Reflections: Colorectal Cancer Patients with Peritoneal Metastases and Other Metastatic Sites Can Benefit from Radical Multifocal Treatment After Comprehensive Evaluation for Accurate Selection Vahan KepenekianAmaniel KefleyesusOlivier Glehen ASO Author Reflections 12 March 2023 Pages: 4455 - 4456
ASO Visual Abstract: Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases Frédéric SchellAmaniel KefleyesusVahan Kepenekian ASO Visual Abstract 08 March 2023 Pages: 4457 - 4458
Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases Ahmed B. HamedYongli ShuaiHaroon A. Choudry Peritoneal Surface Malignancy 21 April 2023 Pages: 4459 - 4470
ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Ahmed B. HamedM. Haroon Choudry ASO Author Reflections 27 April 2023 Pages: 4471 - 4472
ASO Visual Abstract: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases Ahmed B. HamedYongli ShuaiHaroon A. Choudry ASO Visual Abstract 04 May 2023 Pages: 4473 - 4474
Complications and Functional Outcome Differences in Carbon Ion Radiotherapy and Surgery for Malignant Bone Tumors of the Pelvis: A Multicenter, Cohort Study Liuzhe ZhangToru AkiyamaTatsuya Ohno Sarcoma 28 February 2023 Pages: 4475 - 4484
ASO Author Reflections: Long-Term Perspective in Choosing Between Carbon-Ion Radiotherapy and Surgery for Malignant Pelvic Bone Tumors Liuzhe ZhangToru AkiyamaTatsuya Ohno ASO Author Reflections 28 February 2023 Pages: 4485 - 4486
ASO Visual Abstract: Complications and Functional Outcome Differences in Carbon Ion Radiotherapy and Surgery for Malignant Bone Tumors of the Pelvis—A Multicenter Cohort Study Liuzhe ZhangToru AkiyamaTatsuya Ohno ASO Visual Abstract 18 April 2023 Pages: 4487 - 4488
Patterns of Metastatic Recurrence of Genetically Confirmed Myxoid Liposarcoma Pauliina HomsyTom BöhlingCarl Blomqvist Sarcoma Open access 12 March 2023 Pages: 4489 - 4497
ASO Author Reflections: Patterns of Metastatic Recurrence of Genetically Confirmed Myxoid Liposarcoma Pauliina HomsyCarl Blomqvist ASO Author Reflections Open access 27 March 2023 Pages: 4498 - 4498
ASO Visual Abstract: Patterns of Metastatic Recurrence of Genetically Confirmed Myxoid Liposarcoma Pauliina HomsyTom BöhlingCarl Blomqvist ASO Visual Abstract 31 March 2023 Pages: 4499 - 4499
Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal Liposarcomas Luca ImprotaSandro PasqualiAlessandro Gronchi Sarcoma 17 March 2023 Pages: 4500 - 4510
ASO Author Reflections: Organ Infiltration in Retroperitoneal Liposarcomas: A Novel Prognostic Factor? Luca ImprotaSandro PasqualiAlessandro Gronchi ASO Author Reflections 10 April 2023 Pages: 4511 - 4512
ASO Visual Abstract: Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal Liposarcomas Luca ImprotaSandro PasqualiAlessandro Gronchi ASO Visual Abstract 28 April 2023 Pages: 4513 - 4514
Significant Predictors of Postoperative Morbidity After Radical Resection of Retroperitoneal Sarcoma in a Tertiary Center Claudia Di PrataBenjamin RenoufSylvie Bonvalot Sarcoma 09 May 2023 Pages: 4515 - 4526
ASO Author Reflections: Surgical Morbidity of Retroperitoneal Sarcoma Claudia Di PrataSylvie Bonvalot ASO Author Reflections 25 April 2023 Pages: 4527 - 4528
ASO Visual Abstract: Significant Predictors of Postoperative Morbidity After Radical Resection of Retroperitoneal Sarcoma in a Tertiary Center Claudia Di PrataBenjamin RenoufSylvie Bonvalot ASO Visual Abstract 11 May 2023 Pages: 4529 - 4530
First Comparison of Retroperitoneal Versus Transperitoneal Robot-Assisted Nephroureterectomy with Bladder Cuff: A Single Center Study P. SparwasserL. FreyI. Tsaur Urologic Oncology 26 April 2023 Pages: 4531 - 4539
ASO Visual Abstract: First Comparison of Retroperitoneal Versus Transperitoneal Robot-Assisted Nephroureterectomy with Bladder Cuff: A Single-Center Study Peter SparwasserL. FreyI. Tsaur ASO Visual Abstract 10 May 2023 Pages: 4540 - 4540
Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System Anna Carolina Borges da SilvaLuís Gustavo Morato de ToledoFábio Lewin Urologic Oncology 30 March 2023 Pages: 4541 - 4549
ASO Author Reflections: PSMA PET in the Prostate Cancer Primary Staging Scenario—A Reliable Method with a Remarkable Decision-Making Impact Anna Carolina Borges da SilvaLuís Gustavo Morato de Toledo ASO Author Reflections 03 April 2023 Pages: 4550 - 4551
ASO Visual Abstract: Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System Anna Carolina Borges da SilvaLuís Gustavo Morato de ToledoFábio Lewin ASO Visual Abstract 17 April 2023 Pages: 4552 - 4552